Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

BACKGROUND: Selective cyclooxygenase-2 inhibitors and conventional non-selective non-steroidal anti-inflammatory drugs (nsNSAIDs) have been associated with adverse cardiovascular (CV) effects. We compared the CV safety of switching to celecoxib vs. continuing nsNSAID therapy in a European setting. M...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Heart J
Egile Nagusiak: MacDonald, Thomas M., Hawkey, Chris J., Ford, Ian, McMurray, John J.V., Scheiman, James M., Hallas, Jesper, Findlay, Evelyn, Grobbee, Diederick E., Hobbs, F.D. Richard, Ralston, Stuart H., Reid, David M., Walters, Matthew R., Webster, John, Ruschitzka, Frank, Ritchie, Lewis D., Perez-Gutthann, Susana, Connolly, Eugene, Greenlaw, Nicola, Wilson, Adam, Wei, Li, Mackenzie, Isla S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837371/
https://ncbi.nlm.nih.gov/pubmed/27705888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw387
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak